James B. Murray

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1.1K citations

Medicine, Oncology, Pharmacology +11

Capturing the Structure of a Catalytic RNA Intermediate: The Hammerhead Ribozyme

W. G. Scott, James B. Murray, John R. P. Arnold et al. · Science · 1996 · 409 citations

Life Sciences, Biochemistry, Molecular Biology +17

Crystal structure of an RNA bacteriophage coat protein–operator complex

K. Valegård, James B. Murray, Peter G. Stockley et al. · Nature · 1994 · 380 citations

Life Sciences, Microbiology, Molecular Biology +12

The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone

James B. Murray, Attila A. Seyhan, Nils G. Walter et al. · Chemistry & Biology · 1998 · 374 citations · Full text

Natural Sciences, Biochemistry, Chemistry +12

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

Andrew J. Massey, D.S. Williamson, Helen Browne et al. · Cancer Chemotherapy and Pharmacology · 2009 · 329 citations · Full text

Medicine, Oncology, Pharmacology +16